Skip to main content
Payam Nahid, MD, Pulmonology, San Francisco, CA

Payam Nahid MD

Critical Care Medicine, Pleural Disease


Associate Professor, Medicine, UCSF School of Medicine

Join to View Full Profile
  • 1001 Potrero Ave5k1San Francisco, CA 94110

  • Phone+1 415-206-8313

  • Fax+1 415-695-1551

Are you Dr. Nahid?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Payam Nahid, MD is a pulmonologist in San Francisco, California. He is currently licensed to practice medicine in California. He is an Associate Professor at UCSF School of Medicine.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
  • Scripps Clinic/Scripps Green Hospital
    Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 1998 - 2001
  • University of California (Irvine)
    University of California (Irvine)Internship, Internal Medicine, 1997 - 1998
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2026
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • The Fight Against TB Was Frozen in Time, Until Now. See Its Future
    The Fight Against TB Was Frozen in Time, Until Now. See Its FutureMarch 4th, 2025
  • UCSF Joins $200 Million Global Tuberculosis Consortium
    UCSF Joins $200 Million Global Tuberculosis ConsortiumAugust 2nd, 2022
  • Study: Four-Month Regimen of Anti-TB Drugs Works Just as Well as Standard Regimen
    Study: Four-Month Regimen of Anti-TB Drugs Works Just as Well as Standard RegimenMay 24th, 2021
  • Join now to see all

Grant Support

  • UCSF-UCB Tuberculosis Research Advancement Center (TRAC)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
  • DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2026
  • C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB StudyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2025
  • C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB StudyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2025
  • C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB StudyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2025
  • C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB StudyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2025
  • C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB StudyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2025
  • Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
  • TB Research And Mentorship Program (TB RAMP)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
  • TB Research And Mentorship Program (TB RAMP)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
  • TB Research And Mentorship Program (TB RAMP)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
  • TB Research And Mentorship Program (TB RAMP)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025